Skip to content

EQUIMEDIC

Active Private limited company (pre-2019)founded 2008active for 18 yearsEkerstraat 5, 3540 Herk-de-StadKBO/BCE: BE 0806.409.104
EQUIMEDIC
Follow ReportCompare

Overview

Lifetime

16 annual accounts with figures on one time axis
peak €115,569 (2020)
€60,489▼ 14.6%
lowest -€6,689 (2011)
€18,445▼ 42.5%
peak €343,196 (2023)
€297,968▼ 13.2%
€269,146▲ 202%
Board2 names since 2015
2 directorsAUWERX Winde and 1 other
Documentsfilings and deeds
08-12-2025130 days late
2024micro format
Gross margin from €70,816 to €60,489Result from €32,070 to €18,445Dividend €63,674Equity from €343,196 to €297,968Debts from €89,213 to €269,146Cash from €58,340 to €96,876

Key points

from the 2024 annual accounts

Equity

€297,968 ▼ 13.2%
343,1962023+18,445Profit-63,674Dividend297,9682024

EQUIMEDIC paid out €63,674 in dividends. That is 345% of the 2024 profit.

Filings

16 annual accounts 102 days past the deadline
AprilJune31 JulyOctober201020152020

2025 accounts not filed: deadline was 31-07-2026.

Position in the sector

€297,968

More equity than 90% of companies in retail trade. Sector median €39,278 · 25,612 companies.

Checked score

55
Fair
Financially stronger than 43% of micro companies in retail trade (NACE 47)
Probability in this band: 1.5% to 4.2%

A confirmed filing finding caps the score at 59.

Bankruptcy probability within 12 months
1.1% Low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: 0.6% across 40,275 companies (NACE 47, micro).

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024lowest value 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025 08-2025: 0.3%▲ +0.1 percentage points vs 07-2025 09-2025: 0.4%▲ +0.1 percentage points vs 08-2025 10-2025: 0.5%▲ +0.1 percentage points vs 09-2025 11-2025: 0.6%▲ +0.1 percentage points vs 10-2025 12-2025: 0.8%▲ +0.2 percentage points vs 11-2025 01-2026: 0.4%▼ -0.4 percentage points vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.4%● unchanged vs 02-2026 04-2026: 0.4%● unchanged vs 03-2026 05-2026: 0.4%● unchanged vs 04-2026 06-2026: 0.4%● unchanged vs 05-2026 07-2026: 0.4%● unchanged vs 06-2026 08-2026: 0.7%▲ +0.3 percentage points vs 07-2026 09-2026: 0.7%● unchanged vs 08-2026 10-2026: 1.1%▲ +0.4 percentage points vs 09-2026highest value 11-2026: 1.1%● unchanged vs 10-2026highest value

Financial strength
Average

78-22equity 52.5% of total assets
49-14short-term debt 45.5% · cash 17.1%
46-10return on assets 3.3%

Score breakdown

raises risk
Capped at 59: a confirmed filing finding
1 financial year not filed after the legal deadline; last filed accounts filed 130 days late; 2 of the last 3 accounts late
Figures for financial year 2024 (filed on 11-12-2025)
lowers risk
Founded in 2008
Liquidity: current ratio 1.94, cash €96,876
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 66% of them on solvency, 49% on liquidity, 34% on profitability and 24% on growth.

The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2024.

Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 6,049 companies had the same profile as EQUIMEDIC has now. Each dot stands for 16 companies, two years later.

95.9%
were still trading
3.6%
stopped another way
0.4%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet

The bankruptcy probability of EQUIMEDIC itself is higher: 1.1% within 12 months. It rests on far more data about EQUIMEDIC than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,049 companies, not a prediction for EQUIMEDIC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €16,000 on 30-day terms, only on tighter conditions: an expected filing is missing beyond Checked's processing allowance

Liquidity is ample, with a current ratio of 1.94 (5.0 in 2023), above the usual 1.5. Short-term debt is 45.5% and cash 17.1% of total assets. 47.5% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
raises risk · 1 financial year not filed after the legal deadline; last filed accounts filed 130 days late; 2 of the last 3 accounts late
NBB · filings
raises risk · Figures for financial year 2024 (filed on 11-12-2025)
NBB · annual accounts
lowers risk · Founded in 2008
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Liquidity: current ratio 1.94, cash €96,876
NBB · annual accounts
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 102 days later.
NBB · 10 filings
Position against the passed deadline
31-12-2025 year end31-07-2026 deadline10-11-2026 today
raises risk · 2024 accounts filed 130 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 08-12-2025, 130 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers.
NBB · 10 filings
Deviation from the deadline
2025
not filed
2024
130 days late
2023
30 days late
2022
32 days late
2021
26 days late
2020
26 days late
2019
39 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 47 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

AW
AUWERX Winde
Director, since 23-11-2015
MF
Mijten Frederik
Director, since 23-11-2015
Board & ownership

Recent changes

Registered office moved from Stevoort to Herk-de-Stad New registered office: Ekerstraat 5 3540 Herk-de-Stad · Previous registered office: ALkenstraat 80 3512 Stevoort · General meeting of 07-02-2018 · Gazette deed
First establishment Wijerstraat 127, Hasselt
Incorporation published on 25-09-2008 · Gazette deed
All 27 events

Comparable companies

same main activity, similar in size and age
Company
EQUIMEDIC Herk-de-Stad €567,113 €60,489 52.5% -
COMAGINA Beringen €497,519 €88,982 62.7% -
De Mars Lebbeke €444,356 €77,873 50.2% -
HUSTINX AQUARISTIEK Hasselt €435,295 €104,311 46.9% 2.6
ETS ENFANTS DE BUSSCHER Tubize €417,483 €69,961 22.5% -
SAINTE-HERMELLE SPORT HORSES Courcelles €534,240 €51,931 23.7% -
Bocklandt Demeulemeester Veterinary Services Gavere €377,125 €63,403 -11.4% -

These companies have the same main activity as EQUIMEDIC: retail sale of pets, pet food and pet supplies (NACE 47762). They are comparable in size and age: total assets between €377,000 and €534,000, founded between 1999 and 2013.

Official details

Source: KBO
Status
Active since 12-09-2008Normal situation
Activity
Retail sale of pets, pet food and pet suppliesNACE 47762and 3 others
Establishment unit
2.173.703.3853510 Hasselt, since 17-09-2008
Financial year end
31 December
Peppol
Reachable
Company details

Annual accounts 2024

€60,489▼ 14.6%
≈ €290,000estimated
€18,445▼ 42.5%
€297,968▼ 13.2%
€567,113▲ 31.2%
Filing
Filed on 08-12-2025
Financials

Insights on EQUIMEDIC

EQUIMEDIC files the micro format. That format states no turnover. The gross margin rose from €13,911 in 2009 to €60,489 in 2024.

The balance sheet grew most from 2016 to 2017 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2024

micro format, filed on 08-12-2025, 130 days late

2025 annual accounts not yet filed, deadline passed on 31 July 2026 The financial year closed on 31 December 2025. The accounts are due at the latest 7 months after the close (Companies Code art. 3:10). Source: NBB filings, as of 10 November 2026.

€60,489
▼ 14.6%
€28,098
▼ 37.4%
€53,521
▼ 23.1%
€43,868
▼ 22.7%
52.5%
▼ 26.8 percentage points
1.94
▼ 3.06

Turnover and EBIT margin are not published. The abbreviated or micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €290,000. Estimated: probably between €160,000 and €400,000.

Money flows

no detail for 2024

Balance sheet

balance sheet total €567,113 on 31-12-2024
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

52.5%

Higher than 67% of 25,554 companies in 2024.

1.94

Higher than 63% of 24,613 companies in 2024.

3.3%

Higher than 49% of 24,782 companies in 2024.

EQUIMEDIC Middle half of the sector 80% of the sector Micro accounts in retail trade (NACE 47)

Net result: middle half · Equity: top quarter · Balance sheet total: top quarter · Working capital: top quarter

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2024202320222021202020192018201720162015201420132012201120102009
Balance sheet: assets
20/58 567,113432,409465,876430,128364,560349,278298,408406,331272,763152,734202,325109,204106,55486,913100,51556,270
21/28 66,52895,251117,773130,610113,157134,268133,002173,41881,4164,25329,6724,43012,07919,72927,0919,629
22/27 66,52895,251117,773130,610113,157134,268133,002173,41881,4164,25329,6724,43012,07919,72927,0919,629
22 38,40041,60044,80048,00051,20054,40057,60060,800--------
23 6,15019,80927,26728,02238,65744,65165,466100,60269,8003,0665001,0001,5002,000--
24 21,97833,84245,70654,58823,30035,2189,93612,01511,6161,18629,1723,43010,57917,72927,0919,629
29/58 500,585337,158348,103299,518251,404215,010165,406232,913191,347148,481172,653104,77494,47567,18473,42346,641
3 89,37367,150108,930128,380155,830102,50087,31021,55013,64520,30045,6857358,9709,29510,25913,193
30/36 89,37367,150108,930128,380155,830102,50087,31021,55013,64520,30045,6857358,9709,29510,25913,193
40/41 281,337181,535173,918114,68955,32184,17078,096191,757167,70264,693118,798104,03985,49657,88955,08229,630
40 211,77099,584127,81097,36055,23182,30876,380190,817166,46643,825118,798104,03985,49657,11752,00224,433
41 69,56781,95146,10817,329901,8611,7169401,23720,869---7723,0805,197
54/58 96,87658,34041,25538,44926,83221,114-19,60610,00060,4738,170-8-8,0823,818
490/1 33,00030,13224,00018,00013,4217,226---3,015------
Balance sheet: equity and liabilities
10/49 567,113432,409465,876430,128364,560349,278298,408406,331272,763152,734202,325109,204106,55486,913100,51556,270
10/15 297,968343,196311,126310,865281,553217,777182,684125,67588,63571,73442,01236,99634,8407,42014,10911,987
10/11 6,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,200
100 -----18,60018,60018,60018,60018,60018,60018,60018,60018,60018,60018,600
101 -----12,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,400
13 291,768336,996304,926304,665275,353211,577176,484119,47582,43565,53435,81230,7961,8601,8601,8601,860
130/1 1,8601,8601,8601,8601,860-----------
130 -----1,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,860
1311 1,8601,8601,8601,8601,860-----------
133 289,908335,136303,066302,805273,493209,717174,624117,61580,57563,67433,95228,936----
14 ------------26,780-6406,0493,927
17/49 269,14689,213154,750119,26383,007131,501115,724280,656184,12881,001160,31372,20971,71479,49386,40544,283
17 10,90921,77532,98645,21053,73267,36348,68863,806--1,5271,5176,44111,12115,6773,537
170/4 10,90921,77532,98645,21053,73267,36348,68863,806--1,5271,5176,44111,12115,6773,537
42/48 258,23667,438115,76468,05423,27558,13967,036213,649184,12873,891158,65370,69165,27368,37169,63840,746
42 9,77510,27712,48617,511-------4,9244,6804,5557,9704,068
43 -----------3,6572,3498,303--
430/8 -----------3,6572,3498,303--
44 221,96657,161103,27846,8758,33436,52617,628138,36566,1272,79294,25924,99635,02224,91458,22333,209
440/4 221,96657,161103,27846,8758,33436,52617,628138,36566,1272,79294,25924,99635,02224,91458,22333,209
45 13,405--3,6679,73517,49023,85212,7393,33340,03817,5397,2721,3361643,4443,469
450/3 13,405--3,6679,73517,49023,85211,5973,33330,03817,5397,2721,3361643,4443,469
454/9 -------1,141-10,000------
47/48 13,090---5,2064,12325,55762,546114,66831,06146,85529,84221,88630,435--
492/3 --6,0006,0006,0006,000-3,200-7,110133---1,091-
Income statement
70 -------------83,501126,088-
76A ---1,889--6,200-1,0002,7274,132--248--
9900 60,48970,81625,06364,517115,56999,720103,69186,03340,82571,82314,76423,29840,2764,51813,28813,911
60/61 -------------84,680112,800-
630 25,42324,71224,66216,46926,08527,20120,77625,97011,6831,7447,7937,6497,6499,3678,6964,516
640/8 1,4681,2446001,391437713614186535110-5551,6761,4621,69268
66A 5,500----22,159---2,023------
9901 28,09844,861-19946,65789,04649,64782,30059,87728,60769,9686,97115,09430,952-6,3102,9009,327
75/76B --1,2001,767-1,961-56512156--8713103
75 --1,200-----12156--8713103
76B ---1,767-1,961-565--------
65/66B -568-3064081,8791,3961,4342,7872,0555172,2951,0261,7341,819714788184
65 -568-3064081,8791,3961,4342,7872,0555172,2951,0261,7341,819714788184
9903 28,66745,16659346,54587,65150,17479,51358,38628,10168,39210,08413,36029,133-6,6892,1259,246
67/77 10,22213,09633217,23323,87415,08122,50521,34611,20038,6705,06711,2051,712-23,459
9904 18,44532,07026129,31263,77635,09357,00937,04016,90129,7215,0172,15527,420-6,6892,1235,787
9905 18,44532,07026129,31263,77635,09357,00937,04016,90129,7215,0172,15527,420-6,6892,1235,787
Appropriation of the result
9906 18,44532,07026129,31263,77635,09357,00937,04016,90129,7215,01728,93626,780-6406,0495,787
791/2 63,674---------------
691/2 18,44532,07026129,31263,77635,09357,00937,04016,90129,7215,01728,936---1,860
6920 ---------------1,860
6921 18,44532,07026129,31263,77635,09357,00937,04016,90129,7215,01728,936----
694/7 63,674---------------
694 63,674---------------
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 7 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2024 (PDF), filed on 08-12-2025.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2024 micro format 08-12-2025 2025-00579469 PDF
31-12-2023 micro format 30-08-2024 2024-00433141 PDF
31-12-2022 abbreviated format 01-09-2023 2023-00423302 PDF
31-12-2021 abbreviated format 26-08-2022 2022-20341899 PDF
31-12-2020 micro format 26-08-2021 2021-54000137 PDF
31-12-2019 micro format 08-09-2020 2020-52800065 PDF
31-12-2018 micro format 05-08-2019 2019-45200231 PDF
31-12-2017 micro format 25-09-2018 2018-65000582 PDF
31-12-2016 micro format 21-08-2017 2017-45900482 PDF
31-12-2015 abbreviated format 05-08-2016 2016-41500513 PDF
31-12-2014 abbreviated format 27-07-2015 2015-38000020 PDF
31-12-2013 abbreviated format 05-03-2015 2015-05700323 PDF
31-12-2012 abbreviated format 30-08-2013 2013-54200371 PDF
31-12-2011 abbreviated format 31-10-2012 2012-62800468 PDF
31-12-2010 abbreviated format 30-11-2011 2011-62400335 PDF
31-12-2009 abbreviated format 18-10-2010 2010-58300467 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2024202320222021202020192018201720162015201420132012201120102009
53,52169,57224,46363,126115,13176,847103,07685,84740,29071,71314,76422,74438,6013,05711,59513,843
43,86856,78224,92245,78089,86162,29477,78563,01028,58531,46512,8109,80535,0702,67810,81910,303
2,2002,19011,82456,0004,97342,4675,160117,97188,847-23,67533,035002,50026,15914,145
38,53517,0862,80611,6165,719--9,606-50,47352,303----4,264-
242,349269,720232,339231,464228,128156,87198,37019,2647,21974,59014,00034,08329,202-1,1873,7855,895
--------------7.6%2.3%-
52.5%79.4%66.8%72.3%77.2%62.4%61.2%30.9%32.5%47.0%20.8%33.9%32.7%8.5%14.0%21.3%
1.945.003.014.4010.803.702.471.091.042.011.091.481.450.981.051.14
1.594.002.072.514.111.941.160.990.971.730.801.471.310.850.910.82
0.900.260.500.380.290.600.632.232.081.133.821.952.0610.716.123.69
6.2%9.3%0.1%9.4%22.7%16.1%31.2%29.5%19.1%41.4%11.9%5.8%78.7%-90.2%15.0%48.3%
3.3%7.4%0.1%6.8%17.5%10.0%19.1%9.1%6.2%19.5%2.5%2.0%25.7%-7.7%2.1%10.3%
-94.15-227.6059.9533.60------------
-------------250 days151 days-
-------------107 days188 days-

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item2024202320222021
Tangible fixed assets€2,200€2,190€11,824€56,000
€25,423€24,712€24,662€16,469

Source: notes to the 2021 to 2024 annual accounts (statement of fixed assets)

Insights on EQUIMEDIC

The operating result for 2024 is 37% lower than in 2023.

Debt's share of the balance-sheet total rises from 20.6% to 47.5%. Equity is lower and debt is higher.

Board & ownership

Board

2 directors
AUWERX Winde
Director
since 23-11-2015
listed in the 2024 annual accounts, filed on 08-12-2025
Mijten Frederik
Director
since 23-11-2015
listed in the 2024 annual accounts, filed on 08-12-2025

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
AUWERX Winde
Director
Mijten Frederik
Director
Board
Mandates as a list
  • AUWERX Winde
    • Director, from 23-11-2015 to date
  • Mijten Frederik
    • Director, from 23-11-2015 to date

See the board, name and registered office on a given date →

Control

See the annual accounts at the National Bank and the publications in the Belgian Official Gazette.

Capital

Contribution
€6,200
Source
2024 annual accounts

Network & group

No group

EQUIMEDIC has no parent and no holdings in its annual accounts. EQUIMEDIC shares no director with another company.

Timeline

Timeline

27 events since 2008
2025
Annual accounts 2024 filed PDFmicro format · 130 days late
2024
Annual accounts 2023 filed PDFmicro format · 30 days late
2023
Annual accounts 2022 filed PDFabbreviated format · 32 days late
2022
Annual accounts 2021 filed PDFabbreviated format · 26 days late
2021
Annual accounts 2020 filed PDFmicro format · 26 days late
2020
Highest result from 2009 to 2024 net €63,776 ▲81.7% The operating result of €89,046 and the net result of €63,776 are both a record.
Liquidity more than doubled current ratio 10.80 The current ratio rises from 3.70 to 10.80. Short-term debt falls from €58,139 to €23,275.
Annual accounts 2019 filed PDFmicro format · 39 days late
2019
Equity above €200,000 equity €217,777 ▲19.2% After 8 profitable years in a row, equity reaches €217,777.
Annual accounts 2018 filed PDFmicro format · 5 days late
2018
Liquidity more than doubled current ratio 2.47 The current ratio rises from 1.09 to 2.47. Short-term debt falls from €213,649 to €67,036.
Equity above €150,000 equity €182,684 ▲45.4% After 7 profitable years in a row, equity reaches €182,684.
Annual accounts 2017 filed PDFmicro format · 56 days late
Registered office moved from Stevoort to Herk-de-StadNew registered office: Ekerstraat 5 3540 Herk-de-Stad · Previous registered office: ALkenstraat 80 3512 Stevoort · General meeting of 07-02-20182 points ▸
  • General meeting, 07-02-2018
  • Registered-office move, Ekerstraat 5 3540 Herk-de-Stad

Open the deed in the Belgian Official Gazette

2017
Equity above €100,000 equity €125,675 ▲41.8% After 6 profitable years in a row, equity reaches €125,675.
Annual accounts 2016 filed PDFmicro format · 21 days late
2016
Annual accounts 2015 filed PDFabbreviated format · 5 days late
2015
Annual accounts 2014 filed PDFabbreviated format · 4 days before the deadline
Annual accounts 2013 filed PDFabbreviated format · 217 days late
2013
Annual accounts 2012 filed PDFabbreviated format · 30 days late
2012
Back to profit net €27,420 The net result is €27,420, after one loss-making year.
Annual accounts 2011 filed PDFabbreviated format · 92 days late
2011
Weakest financial year net -€6,689 The net result drops to -€6,689, the lowest from 2009 to 2024. It recovers the following year.
Annual accounts 2010 filed PDFabbreviated format · 122 days late
2010
Annual accounts 2009 filed PDFabbreviated format · 79 days late
2008
First establishment Wijerstraat 127, Hasselt
Incorporation PDFpublished on 25-09-2008

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 12 September 2008, EQUIMEDIC was incorporated.1 In 2018 the registered office moved to Herk-de-Stad.2 Total assets went from €298,408 in 2018 to €567,113 in 2024.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 24-04-2018
  3. 3National Bank, annual accounts 2018 and 2024

Company details

Identity

Enterprise number
0806.409.104
VAT number
BE 0806.409.104
Peppol ID
0208:0806409104
Other Peppol ID
9925:BE0806409104
Legal form
Private limited company (pre-2019)
Status
Active, normal situation
Founded
12-09-2008
Financial year
ends on 31 December
Peppol
Reachable via PeppolFollow this company and you will hear the next morning if it leaves the Peppol register.
Name
EQUIMEDIC in Dutch
Entity type
Legal entity

Activities

NACEBEL 2025
47762 Retail sale of pets, pet food and pet supplies main activity
70200 Business and other management consultancy
85510 Sports and recreation education
93199 Other sports activities
Codes under NACEBEL 2008
47762 Retail trade main activity
70220 Business consulting
85510 Sports and recreation education
93199 Other sports activities

Registered office and establishments

1 establishment
Establishment Since Unit number
Ekerstraat 5 registered office 3540 Herk-de-Stad
Wijerstraat 127 3510 Hasselt 17-09-2008 2.173.703.385
1 former office
  • ALkenstraat 80, 3512 Stevoort until 07-02-2018 · deed of 24-04-2018

Buildings and parcels at the addresses

Ground area
3,174 m²
Buildings
213 m²
Volume, LiDAR
1,224 m³
Tallest building
11.0 m
Buildings to scale, each on its own parcel
213 m², 11.0 m 213 m², 11.0 m

Location

registered office establishment The establishment unit on the map

Parcels

Cadastral parcelArea Buildings Height / floors
71054B0255/00H0001,907 m² - -
71003A0144/00R0021,266 m² 1 · 213 m² 11.0 m · 2

We would like to set cookies. That happens only with your consent. What we measure